ConductScience.org, home

Library / Trial comparisons

SMART-AI vs Usual Care: All-cause Re-hospitalizations Following 6-months From the Index Hospital Encounter

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.3050.30.31wilsonClinicalTrials.gov
Risk in group 20.3050.30.31wilsonClinicalTrials.gov
Risk difference, group 1 minus group 20.000206-0.006880.00729newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 210.9781.02logClinicalTrials.gov
Odds ratio, group 1 over group 210.9681.03logClinicalTrials.gov
Number needed to treat, for one more participant with the outcome on SMART-AI than on Usual Care4,850from the risk difference intervalthe interval includes no differenceClinicalTrials.gov

Groups 2

Group 2 names the comparator: usual care.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1SMART-AI
Automated processing of clinical notes collected during routine care in first 24 hours of hospital admission to identify individuals at-risk for substance misuse to receive standard-of-care full screening and assessment, brief intervention, or referral to treatment (SBIRT) intervention.~Processing of clinical notes in the EHR data collected during routine care: Clinical notes collected in the first day of hospital admission during usual care as input to natural language processing and machine learning algorithm.
10,24133,564OG001ClinicalTrials.gov
Group 2Usual CareBefore intervention9,58431,432OG000ClinicalTrials.gov

Outcome 5

FieldValueSource
TypeSECONDARYClinicalTrials.gov
TitleAll-cause Re-hospitalizations Following 6-months From the Index Hospital EncounterClinicalTrials.gov
DescriptionWe will compare healthcare utilization outcomes in all patients between pre- and post-periods controlling for all patient demographic and clinical characteristics.ClinicalTrials.gov
Time frame12 months enrollment with 6 months follow-up for rehospitalizationClinicalTrials.gov
PopulationClinicalTrials.gov

Trial 8

FieldValueSource
TitleData-driven Identification for Substance MisuseClinicalTrials.gov
NCT numberNCT03833804ClinicalTrials.gov
PhasesNAClinicalTrials.gov
ConditionsSubstance Use, Substance Abuse, Substance-Related DisordersClinicalTrials.gov
InterventionsProcessing of clinical notes in the EHR data collected during routine careClinicalTrials.gov
Lead sponsorUniversity of Wisconsin, MadisonClinicalTrials.gov
Results first posted2025-10-24ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT03833804?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.